European Monitoring Centre for Drugs and Drug Addiction
Annual report 2004:
the state of the drugs problem in the European Union and Norway
'There are positive signs that progress has been made in reducing some of the worst consequences of drug use', says Director of the EU drugs agency, Georges Estievenart. 'The trend in drug-related deaths is now downwards after many years on the rise, heroin use has stabilised in many countries, and the HIV epidemic among injecting drug users may be slowing in some new EU Member States. At the same time, measures to reduce drug-related harm are intensifying and, across much of Europe, drug users have better access to treatment and care'.
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO
Specialised drug treatment centres in many EU countries report increasing contact with cannabis users. Overall, after heroin, cannabis has become the next most frequently recorded primary drug for which users are seeking help.
This trend is revealed in the 2004 Annual report on the state of the drugs problem in the European Union and Norway, released today in Brussels by the Lisbon-based EU drugs agency, the EMCDDA. In a special focus on 'cannabis problems in context', the report examines the issues behind this rising demand for treatment for the world's most commonly produced, trafficked and consumed illicit drug.
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO
Information now available on the European drug situation is 'increasingly robust' says the EU drugs agency (EMCDDA) today as it presents its 2004 Annual report on the state of the drugs problem in the European Union and Norway in Brussels.
The statement comes as the EU agency concludes its first 10 years of reporting and offers the first consolidated overview of the European drug phenomenon in 26 countries, from the Atlantic to the Russian border. Over the last decade, the EMCDDA has worked with Member States to develop data-collection tools and indicators to provide countries with a 'common language' with which to describe the drug phenomenon. It has also facilitated the creation of national drug monitoring centres across Europe, which now play a vital role in collecting and interpreting data needed for sound policy-making.
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO
ES | CS | DA | DE | ET | EL | EN | FR | IT | LV | LT | HU | NL | PL | PT | SK | SL | FI | SV | NO